Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,189
datasets available to search
ShareScore release 0.9.0
Dataset results
2,189 results for “AML”
Veneclax, Chidaniline Combined With Azacitidine Followed by Decitabine + MAG Regimen in the Treatment of Elderly Untreated AML
ClinicalTrials.gov study NCT06827899. IPD Sharing: NO. Countries: 1. Publications: 0.
HVA vs IA/DA or VA in the Treatment of ND HR-AML
ClinicalTrials.gov study NCT06810791. IPD Sharing: NO. Countries: 1. Publications: 0.
Trial of LAVA-051 in Patients with Relapsed/refractory CLL, MM, or AML
ClinicalTrials.gov study NCT04887259. IPD Sharing: NO. Countries: 4. Publications: 0.
Idarubicin Plus Cytarabine (IA) vs IA Plus Cladribine (IAC) as Induction Regimen to Treat Initially Diagnosed Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02323022. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of Expanded, Universal Donor Natural Killer Cells for Relapsed/Refractory AML
ClinicalTrials.gov study NCT05503134. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML Considered Ineligible for Intensive Chemotherapy
ClinicalTrials.gov study NCT07075016. IPD Sharing: UNDECIDED. Countries: 16. Publications: 0.
Prexasertib in Combination With MEC in Relapsed/Refractory AML and High Risk MDS - a Phase I Trial
ClinicalTrials.gov study NCT03735446. IPD Sharing: NO. Countries: 1. Publications: 0.
A Single Arm Pilot Study of Azacitidine in Myelodysplastic Syndromes (MDS) / Acute Myeloid Leukaemia (AML), With Eltrombopag Support for Thrombocytopenia
ClinicalTrials.gov study NCT01488565. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dose-Escalation Study of Oral Administration of LP-108 as Monotherapy and in Combination With Azacitidine in Patients With Relapsed or Refractory MDS, CMML, or AML
ClinicalTrials.gov study NCT04139434. IPD Sharing: NO. Countries: 2. Publications: 0.
Imatinib + MTC in Relapsed / Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00744081. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Active Immunotherapy With GRNVAC1 in Patients With Acute Myelogenous Leukemia (AML)
ClinicalTrials.gov study NCT00510133. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Evaluate the Safety and Preliminary Efficacy of CLL1 and CD38 Dual CAR-T in r/r AML
ClinicalTrials.gov study NCT06110208. IPD Sharing: Not stated. Countries: 1. Publications: 0.
QUILT-3.034: Non-Myeloablative TCRa/b Deplete Haplo HSCT With Post ALT-803 for AML
ClinicalTrials.gov study NCT03365661. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prospective Study on Severe Infections on Acute Myeloid Leukemia (AML) Patients
ClinicalTrials.gov study NCT01570465. IPD Sharing: NO. Countries: 1. Publications: 0.
Chimeric Antigen Receptor T-cells for The Treatment of AML Expressing CLL-1 Antigen
ClinicalTrials.gov study NCT04219163. IPD Sharing: NO. Countries: 1. Publications: 0.
Decitabine and Vaccine Therapy for Patients With Relapsed AML Following Allogeneic Stem Cell Transplantation
ClinicalTrials.gov study NCT01483274. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT07306832. IPD Sharing: NO. Countries: 0. Publications: 0.
Phase 3 Trial for AML Patients in CR2 Comparing 8Gy TBI /Fludarabine to Conditioning With TBI 12Gy/Cyclophosphamide
ClinicalTrials.gov study NCT00125606. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study of Anti-FLT3 CAR-T Cells for the Treatment of Relapsed/Refractory AML
ClinicalTrials.gov study NCT06786533. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study of Liposomal Annamycin for the Treatment of Subjects With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT03388749. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.